Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (371-380 of 383) with videos related to

Pageof 39
Sort By:
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Prostate Cancer and Prostatic Diseases|February 13, 2022
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard scoreMinh-Phuong Huynh-Le, Roshan Karunamuni, Chun Chieh Fan, et al.
Nature Communications|February 24, 2021
Polygenic hazard score is associated with prostate cancer in multi-ethnic populationsMinh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, et al.
HGG Advances|January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European AncestryBurcu F Darst, Jiayi Shen, Ravi K Madduri, et al.
European Urology|December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
American Journal of Human Genetics|June 13, 2023
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestryBurcu F Darst, Jiayi Shen, Ravi K Madduri, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Pageof 39

Showing results (371-380 of 383) with videos related to

Sort By:
Pageof 39
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Prostate Cancer and Prostatic Diseases|February 13, 2022
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard scoreMinh-Phuong Huynh-Le, Roshan Karunamuni, Chun Chieh Fan, et al.
Nature Communications|February 24, 2021
Polygenic hazard score is associated with prostate cancer in multi-ethnic populationsMinh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, et al.
HGG Advances|January 7, 2022
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J Meyers, Adaeze A Emeka, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European AncestryBurcu F Darst, Jiayi Shen, Ravi K Madduri, et al.
European Urology|December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
American Journal of Human Genetics|June 13, 2023
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestryBurcu F Darst, Jiayi Shen, Ravi K Madduri, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Pageof 39